Schjesvold, Fredrik H. Dimopoulos, Meletios-Athanasios and Delimpasi, Sosana Robak, Pawel Coriu, Daniel Legiec, Wojciech Pour, Ludek Spicka, Ivan Masszi, Tamas Doronin, Vadim Minarik, Jiri Salogub, Galina Alekseeva, Yulia and Lazzaro, Antonio Maisnar, Vladimir Mikala, Gabor Rosinol, Laura Liberati, Anna Marina Symeonidis, Argiris Moody, Victoria Thuresson, Marcus Byrne, Catriona Harmenberg, Johan and Bakker, Nicolaas A. Hajek, Roman Mateos, Maria-Victoria and Richardson, Paul G. Sonneveld, Pieter OCEAN OP-103 Investigators, Melflufen or pomalidomide plus dexamethasone for patients with multiple
myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head,
open-label, phase 3 study, The Lancet Haematology, (9), E98-E110, 2022, Elsevier Sci Ltd, Exeter, United Kingdom, 2352-3026